NOTE: As provided in LFC policy, this report is intended for use by the standing finance committees of the legislature. The Legislative Finance Committee does not assume responsibility for the accuracy of the information in this report when used in any other situation.
Only the most recent FIR version, excluding attachments, is available on the Intranet. Previously issued FIRs and attachments may be obtained from the LFC office in Suite 101 of the State Capitol Building North.
SPONSOR: | King | DATE TYPED: | 02/15/01 | HB | 537 | ||
SHORT TITLE: | Prescription Drug ID Cards | SB | |||||
ANALYST: | Wilson |
Recurring
or Non-Rec |
Fund
Affected | ||||
FY01 | FY02 | FY01 | FY02 | ||
See Narrative |
(Parenthesis ( ) Indicate Expenditure Decreases)
SOURCES OF INFORMATION
Public Regulation Commission
Health Policy Commission (HPC)
General Services Department (GSD)
Attorney General's Office (AG)
SUMMARY
Synopsis of Bill
HB 537 requires the Superintendent of Insurance, following guidelines recommended by a national council for prescription drug programs, to design a uniform prescription drug identification card to be utilized by all health insurers, HMOs, managed care organizations, pharmacy benefit managers, and prescription drug purchasing cooperative functioning with a self-insurance plan or by any other method.
Significant Issues.
FISCAL IMPLICATIONS
The PRC wrote that "the costs of implementing the provisions of HB 537 are unknown, but could be substantial.
ADMINISTRATIVE IMPLICATIONS
The PRC was not able to estimate the administrative costs.
TECHNICAL ISSUES
The AG states that HB 537 does not explicitly require regulations. They also note that HB 537 should specifically identify the "national council."
OTHER SUBSTANTIVE ISSUES
DW/ar